Biotech stocks have fallen to earth with a thud in 2021 after soaring last year amid excitement over the development of Covid-19 vaccines, dealing big losses to some hedge funds.
The sector is being buffeted by concerns Congress will move to put a lid on drug pricing and a surfeit of early-stage biotech shares as the IPO market booms.
Studying Time: 3 minutes The Nicki Minaj vs. Cardi B beef has been occurring for years. Like, mainly for so…
Studying Time: 3 minutes For starters, insiders now declare that City already…
We independently consider all really useful services. Any services or products put…
BuzzFeed Inc. posted a wider quarterly loss amid rising costs…
